Growth Metrics

Regeneron Pharmaceuticals (REGN) Debt to Equity (2020 - 2026)

Regeneron Pharmaceuticals' quarterly Debt to Equity came in at $0.06 in Q1 2026, down 6.41% year-on-year from $0.07 in Q1 2025, and down 0.52% quarter-over-quarter from $0.06 in Q4 2025.

Regeneron Pharmaceuticals has reported Debt to Equity for 7 years, with the latest figure at $0.06 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity fell 6.41% year-over-year to $0.06; the trailing twelve-month figure through Mar 2026 stood at $0.06 (down 6.41% YoY), and the FY2025 full-year result was $0.06, down 6.01% from the prior year.
  • Debt to Equity for Q1 2026 stood at $0.06, down from $0.06 in the prior quarter.
  • The five-year high for Debt to Equity was $0.1 in Q1 2022, with the low at $0.06 in Q1 2026.
  • Average Debt to Equity over 5 years is $0.08, with a median of $0.07 recorded in 2024.
  • Year-over-year, Debt to Equity plunged 39.81% in 2022 and dropped 5.2% in 2025.
  • Tracing REGN's Debt to Equity over 5 years: stood at $0.09 in 2022, then dropped by 12.67% to $0.08 in 2023, then dropped by 11.45% to $0.07 in 2024, then retreated by 6.01% to $0.06 in 2025, then fell by 0.52% to $0.06 in 2026.
  • The last three Debt to Equity figures came in at $0.06 (Q1 2026), $0.06 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.06
Dec 31, 2025 0.06
Sep 30, 2025 0.06
Jun 30, 2025 0.07
Mar 31, 2025 0.07
Dec 31, 2024 0.07
Sep 30, 2024 0.07
Jun 30, 2024 0.07
Mar 31, 2024 0.07
Dec 31, 2023 0.08
Sep 30, 2023 0.08
Jun 30, 2023 0.08
Mar 31, 2023 0.08
Dec 31, 2022 0.09
Sep 30, 2022 0.09
Jun 30, 2022 0.10
Mar 31, 2022 0.10
Dec 31, 2021 0.11
Sep 30, 2021 0.11
Jun 30, 2021 0.13
Mar 31, 2021 0.17
Dec 31, 2020 0.18
Sep 30, 2020 0.20
Jun 30, 2020 0.17